Pharmaceutical expenditure changes under the volume-based procurement policy: Effects and influencing factors
VBP policy effectively promoted the decline of total drug expenditures, primarily through manufacturer-level market displacement and the absolute price reduction. However, the "spillover effect" of alternative drugs weakened the overall effect on cost control. Strengthening holistic governance and improving the quality and intensiveness of drug use are important directions for future policy perfection.
Authors
- Furong Wang (ORCID: https://orcid.org/0000-0001-8693-7301)
- Ying Yang (ORCID: https://orcid.org/0000-0001-9252-5071)
- Lei Zhou (ORCID: https://orcid.org/0000-0003-0894-675X)
- Sisheng Gan
- Yuanhui Duan (ORCID: https://orcid.org/0000-0002-5564-4394)
- Zongfu Mao (ORCID: https://orcid.org/0000-0001-9477-4725)
Institutions
- Wuhan University (CN)
- Wuhan Donghu University (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1371/journal.pone.0330296
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Postdoctoral Science Foundation of Hubei Province
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Postdoctoral Research Foundation of China